DE69822814D1 - Zusammensetzung enthalten Cyclsoporin in einem hydrophilen Träger - Google Patents

Zusammensetzung enthalten Cyclsoporin in einem hydrophilen Träger

Info

Publication number
DE69822814D1
DE69822814D1 DE69822814T DE69822814T DE69822814D1 DE 69822814 D1 DE69822814 D1 DE 69822814D1 DE 69822814 T DE69822814 T DE 69822814T DE 69822814 T DE69822814 T DE 69822814T DE 69822814 D1 DE69822814 D1 DE 69822814D1
Authority
DE
Germany
Prior art keywords
propylene glycol
hydrophilic carrier
cyclsoporin
cyclosporin
composition contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69822814T
Other languages
English (en)
Other versions
DE69822814T2 (de
Inventor
Amarjit Singh
Rajesh Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of DE69822814D1 publication Critical patent/DE69822814D1/de
Application granted granted Critical
Publication of DE69822814T2 publication Critical patent/DE69822814T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69822814T 1998-08-18 1998-08-18 Zusammensetzung enthaltend Cyclosporin in einem hydrophilen Träger Expired - Lifetime DE69822814T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98306607A EP0982035B1 (de) 1998-08-18 1998-08-18 Zusammensetzung enthalten Cyclsoporin in einem hydrophilen Träger
RU98115892/14A RU2178293C2 (ru) 1998-08-18 1998-08-18 Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул
CNB981185851A CN1199642C (zh) 1998-08-18 1998-09-04 含环孢菌素的新型药物组合物
CA002249675A CA2249675A1 (en) 1998-08-18 1998-10-06 A novel composition containing cyclosporin

Publications (2)

Publication Number Publication Date
DE69822814D1 true DE69822814D1 (de) 2004-05-06
DE69822814T2 DE69822814T2 (de) 2005-01-27

Family

ID=31999277

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69822814T Expired - Lifetime DE69822814T2 (de) 1998-08-18 1998-08-18 Zusammensetzung enthaltend Cyclosporin in einem hydrophilen Träger
DE69921409T Expired - Lifetime DE69921409T2 (de) 1998-08-18 1999-08-16 Cyclosporin enthaltende Zusammensetzungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69921409T Expired - Lifetime DE69921409T2 (de) 1998-08-18 1999-08-16 Cyclosporin enthaltende Zusammensetzungen

Country Status (9)

Country Link
EP (2) EP0982035B1 (de)
CN (1) CN1199642C (de)
AT (1) ATE262916T1 (de)
CA (1) CA2249675A1 (de)
DE (2) DE69822814T2 (de)
DK (1) DK0982035T3 (de)
ES (1) ES2215277T3 (de)
PT (1) PT982035E (de)
RU (1) RU2178293C2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2257917C2 (ru) * 1998-12-11 2005-08-10 Фармасолюшнз, Инк. Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов
JP2003512436A (ja) 1999-10-27 2003-04-02 アレクサンドラ ルーカス、 移植片拒絶を防止及び治療するための組成物及び方法
GB2362573A (en) * 2000-05-25 2001-11-28 Cipla Ltd Cyclosporin formulation
PT1151755E (pt) * 2000-05-04 2005-05-31 Panacea Biotec Ltd Composicoes farmaceuticas compreendendo a ciclosporina como substancia activa
AU2001225459B2 (en) 2000-09-18 2005-12-22 Rpg Life Sciences Limited Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
JP2004509171A (ja) 2000-09-29 2004-03-25 ゾーン、　ロバート　ズィー． 炎症及び免疫反応の治療方法及びその組成物
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
IN2014MN02213A (de) * 2012-05-10 2015-07-10 Painreform Ltd
CN103301068B (zh) * 2013-07-08 2014-09-10 广东彼迪药业有限公司 一种头孢克肟干混悬剂剂及其制备方法
CN103462914B (zh) * 2013-09-04 2015-12-09 南京正宽医药科技有限公司 一种头孢克肟片剂及其制备方法
CN111789943B (zh) * 2019-04-08 2024-01-19 洛阳赛威生物科技有限公司 一种水包油佐剂组合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
DE69435104D1 (de) * 1993-09-28 2008-07-31 Scherer Gmbh R P Herstellung von Weichgelatinekapseln
IT1277338B1 (it) * 1995-07-25 1997-11-10 Poli Ind Chimicia S P A Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
CA2278675A1 (en) * 1997-01-30 1998-08-06 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil

Also Published As

Publication number Publication date
ES2215277T3 (es) 2004-10-01
EP0985412A3 (de) 2001-05-02
ATE262916T1 (de) 2004-04-15
RU2178293C2 (ru) 2002-01-20
CN1199642C (zh) 2005-05-04
CA2249675A1 (en) 2000-04-06
EP0985412A2 (de) 2000-03-15
EP0982035A1 (de) 2000-03-01
DE69921409T2 (de) 2006-03-09
EP0985412B1 (de) 2004-10-27
EP0982035B1 (de) 2004-03-31
PT982035E (pt) 2004-08-31
DK0982035T3 (da) 2004-06-28
DE69822814T2 (de) 2005-01-27
DE69921409D1 (de) 2004-12-02
CN1247060A (zh) 2000-03-15

Similar Documents

Publication Publication Date Title
DE69822814D1 (de) Zusammensetzung enthalten Cyclsoporin in einem hydrophilen Träger
NZ512771A (en) Pharmaceutical composition containing omeprazole in a hydrophobic oily liquid vechicle
EP0950399A3 (de) Riechstoff-Zusammensetzungen mit antimikrobieller Wirkung
CA2200966A1 (en) Pharmaceutical compositions
CA2117957A1 (en) Pour point depressants for industrial lubricants containing mixtures of fatty acid esters and vegetable oils
ES2153686T3 (es) Composiciones liquidas de limpieza para multiples usos en microemulsion.
DE59505676D1 (de) Synthetische ester aus alkoholen und fettsäuregemischen aus ölsäurereichen, stearinsäurearmen pflanzenölen
ES2157592T3 (es) Composiciones limpiadoras liquidas en forma de microemulsion, para cualquier uso.
DE69706318D1 (de) Zusammensetzungen für antitranspirante fest-gel stifte
DE60018715D1 (de) Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil
CA2380951A1 (en) Pharmaceutical compositions for oral and topical administration
WO2001091587A3 (en) Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain
WO1999016410A3 (en) Low residue solid antiperspirant
CA2306628A1 (en) Cosmetic formulations for the prevention and therapy of hair loss
MY133026A (en) Cosmetic pit emulsions
ATE279199T1 (de) Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten
DE60135927D1 (en) Nd
DE69809743T2 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
ATE335461T1 (de) Hautpräparat
CA2197413A1 (en) A pharmaceutical or veterinary composition
BR9802667C2 (pt) Composições farmacêuticas contendo ciclosporina como ingrediente ativo
RU99102624A (ru) Смазочно-охлаждающее технологическое средство "тамойл"
RU97106957A (ru) Дезодорирующее средство для воздуха
DE69500228T2 (de) Verwendung einer Zusammensetzung enthaltend einen Alkohol und eine Phosphate-Verbindung als Abschminkmittel
GR1001364B (el) Από του στόματος συν?έσεις ουβιδεκαρενόνης υπό μορφήν υδατικών διαλυμάτων.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition